Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
33
TLRY.TO Quote, Financials, Valuation and Earnings
Last price:
$13.85
Seasonality move
:
10.74%
Day range:
$13.66 - $14.55
52-week range:
$4.85 - $32.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.46x
P/B ratio:
0.76x
Volume:
260.5K
Avg. volume:
774K
1-year change:
-31.44%
Market cap:
$1.6B
Revenue:
$1.1B
EPS (TTM):
-$3.21
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TLRY.TO
Tilray Brands, Inc.
|
$292.3M | -- | 4.8% | -100% | $16.82 |
|
ACB.TO
Aurora Cannabis, Inc.
|
$86.5M | -$0.03 | 4.79% | -91.67% | $7.80 |
|
BAMM.CX
Body & Mind, Inc.
|
-- | -- | -- | -- | -- |
|
CRON.TO
Cronos Group, Inc.
|
$51.3M | -$0.07 | 33.92% | -156.68% | $3.95 |
|
OGI.TO
Organigram Global, Inc.
|
$73M | -$0.01 | 71.72% | -80% | $3.40 |
|
WEED.TO
Canopy Growth Corp.
|
$71.8M | -$0.11 | -5.09% | -95.48% | $3.76 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TLRY.TO
Tilray Brands, Inc.
|
$13.85 | $16.82 | $1.6B | -- | $0.00 | 0% | 3.46x |
|
ACB.TO
Aurora Cannabis, Inc.
|
$6.27 | $7.80 | $354.7M | 116.20x | $0.00 | 0% | 0.96x |
|
BAMM.CX
Body & Mind, Inc.
|
$0.03 | -- | $3.7M | -- | $0.00 | 0% | 0.15x |
|
CRON.TO
Cronos Group, Inc.
|
$3.76 | $3.95 | $1.4B | 28.61x | $0.00 | 0% | 7.82x |
|
OGI.TO
Organigram Global, Inc.
|
$2.41 | $3.40 | $324.1M | 129.47x | $0.00 | 0% | 1.20x |
|
WEED.TO
Canopy Growth Corp.
|
$1.78 | $3.76 | $609.1M | -- | $0.00 | 0% | 1.16x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TLRY.TO
Tilray Brands, Inc.
|
17.36% | 5.879 | 21.31% | 1.39x |
|
ACB.TO
Aurora Cannabis, Inc.
|
15.87% | 1.055 | 19.86% | 1.52x |
|
BAMM.CX
Body & Mind, Inc.
|
-69.4% | -5.214 | 41.11% | 0.24x |
|
CRON.TO
Cronos Group, Inc.
|
0.16% | 1.773 | 0.16% | 20.73x |
|
OGI.TO
Organigram Global, Inc.
|
2.45% | 2.654 | 2.31% | 1.21x |
|
WEED.TO
Canopy Growth Corp.
|
26.05% | 4.059 | 38.43% | 4.06x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TLRY.TO
Tilray Brands, Inc.
|
$73.5M | -$14.9M | -75.86% | -86.4% | -5.19% | -$14.9M |
|
ACB.TO
Aurora Cannabis, Inc.
|
-$8M | -$56M | -9.13% | -10.69% | -61.96% | -$46.7M |
|
BAMM.CX
Body & Mind, Inc.
|
$2.7M | -$1.8M | -229.73% | -- | -45.57% | -$1.8M |
|
CRON.TO
Cronos Group, Inc.
|
$24.8M | -$6.9M | 3.71% | 3.71% | -13.83% | $12.4M |
|
OGI.TO
Organigram Global, Inc.
|
$416K | -$28M | -6.89% | -7.06% | -35.03% | -$554K |
|
WEED.TO
Canopy Growth Corp.
|
$16.9M | -$16.4M | -39.84% | -68.7% | -24.59% | -$19.4M |
Tilray Brands, Inc. vs. Competitors
-
Which has Higher Returns TLRY.TO or ACB.TO?
Aurora Cannabis, Inc. has a net margin of 0.72% compared to Tilray Brands, Inc.'s net margin of -58.83%. Tilray Brands, Inc.'s return on equity of -86.4% beat Aurora Cannabis, Inc.'s return on equity of -10.69%.
Company Gross Margin Earnings Per Share Invested Capital TLRY.TOTilray Brands, Inc.25.56% -$0.00 $2.5B ACB.TOAurora Cannabis, Inc.-8.86% -$0.91 $667.4M -
What do Analysts Say About TLRY.TO or ACB.TO?
Tilray Brands, Inc. has a consensus price target of $16.82, signalling upside risk potential of 21.44%. On the other hand Aurora Cannabis, Inc. has an analysts' consensus of $7.80 which suggests that it could grow by 24.4%. Given that Aurora Cannabis, Inc. has higher upside potential than Tilray Brands, Inc., analysts believe Aurora Cannabis, Inc. is more attractive than Tilray Brands, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLRY.TOTilray Brands, Inc.2 6 0 ACB.TOAurora Cannabis, Inc.2 2 0 -
Is TLRY.TO or ACB.TO More Risky?
Tilray Brands, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Aurora Cannabis, Inc. has a beta of 1.098, suggesting its more volatile than the S&P 500 by 9.781%.
-
Which is a Better Dividend Stock TLRY.TO or ACB.TO?
Tilray Brands, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurora Cannabis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tilray Brands, Inc. pays -- of its earnings as a dividend. Aurora Cannabis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLRY.TO or ACB.TO?
Tilray Brands, Inc. quarterly revenues are $287.4M, which are larger than Aurora Cannabis, Inc. quarterly revenues of $90.4M. Tilray Brands, Inc.'s net income of $2.1M is higher than Aurora Cannabis, Inc.'s net income of -$53.2M. Notably, Tilray Brands, Inc.'s price-to-earnings ratio is -- while Aurora Cannabis, Inc.'s PE ratio is 116.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tilray Brands, Inc. is 3.46x versus 0.96x for Aurora Cannabis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLRY.TOTilray Brands, Inc.3.46x -- $287.4M $2.1M ACB.TOAurora Cannabis, Inc.0.96x 116.20x $90.4M -$53.2M
-
Which has Higher Returns TLRY.TO or BAMM.CX?
Body & Mind, Inc. has a net margin of 0.72% compared to Tilray Brands, Inc.'s net margin of -58.94%. Tilray Brands, Inc.'s return on equity of -86.4% beat Body & Mind, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TLRY.TOTilray Brands, Inc.25.56% -$0.00 $2.5B BAMM.CXBody & Mind, Inc.44.58% -$0.03 -$9M -
What do Analysts Say About TLRY.TO or BAMM.CX?
Tilray Brands, Inc. has a consensus price target of $16.82, signalling upside risk potential of 21.44%. On the other hand Body & Mind, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Tilray Brands, Inc. has higher upside potential than Body & Mind, Inc., analysts believe Tilray Brands, Inc. is more attractive than Body & Mind, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLRY.TOTilray Brands, Inc.2 6 0 BAMM.CXBody & Mind, Inc.0 0 0 -
Is TLRY.TO or BAMM.CX More Risky?
Tilray Brands, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Body & Mind, Inc. has a beta of -0.804, suggesting its less volatile than the S&P 500 by 180.423%.
-
Which is a Better Dividend Stock TLRY.TO or BAMM.CX?
Tilray Brands, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Body & Mind, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tilray Brands, Inc. pays -- of its earnings as a dividend. Body & Mind, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLRY.TO or BAMM.CX?
Tilray Brands, Inc. quarterly revenues are $287.4M, which are larger than Body & Mind, Inc. quarterly revenues of $6M. Tilray Brands, Inc.'s net income of $2.1M is higher than Body & Mind, Inc.'s net income of -$3.5M. Notably, Tilray Brands, Inc.'s price-to-earnings ratio is -- while Body & Mind, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tilray Brands, Inc. is 3.46x versus 0.15x for Body & Mind, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLRY.TOTilray Brands, Inc.3.46x -- $287.4M $2.1M BAMM.CXBody & Mind, Inc.0.15x -- $6M -$3.5M
-
Which has Higher Returns TLRY.TO or CRON.TO?
Cronos Group, Inc. has a net margin of 0.72% compared to Tilray Brands, Inc.'s net margin of 77.94%. Tilray Brands, Inc.'s return on equity of -86.4% beat Cronos Group, Inc.'s return on equity of 3.71%.
Company Gross Margin Earnings Per Share Invested Capital TLRY.TOTilray Brands, Inc.25.56% -$0.00 $2.5B CRON.TOCronos Group, Inc.49.47% $0.09 $1.6B -
What do Analysts Say About TLRY.TO or CRON.TO?
Tilray Brands, Inc. has a consensus price target of $16.82, signalling upside risk potential of 21.44%. On the other hand Cronos Group, Inc. has an analysts' consensus of $3.95 which suggests that it could grow by 5.05%. Given that Tilray Brands, Inc. has higher upside potential than Cronos Group, Inc., analysts believe Tilray Brands, Inc. is more attractive than Cronos Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLRY.TOTilray Brands, Inc.2 6 0 CRON.TOCronos Group, Inc.1 1 0 -
Is TLRY.TO or CRON.TO More Risky?
Tilray Brands, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Cronos Group, Inc. has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.958%.
-
Which is a Better Dividend Stock TLRY.TO or CRON.TO?
Tilray Brands, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cronos Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tilray Brands, Inc. pays -- of its earnings as a dividend. Cronos Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLRY.TO or CRON.TO?
Tilray Brands, Inc. quarterly revenues are $287.4M, which are larger than Cronos Group, Inc. quarterly revenues of $50.1M. Tilray Brands, Inc.'s net income of $2.1M is lower than Cronos Group, Inc.'s net income of $39M. Notably, Tilray Brands, Inc.'s price-to-earnings ratio is -- while Cronos Group, Inc.'s PE ratio is 28.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tilray Brands, Inc. is 3.46x versus 7.82x for Cronos Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLRY.TOTilray Brands, Inc.3.46x -- $287.4M $2.1M CRON.TOCronos Group, Inc.7.82x 28.61x $50.1M $39M
-
Which has Higher Returns TLRY.TO or OGI.TO?
Organigram Global, Inc. has a net margin of 0.72% compared to Tilray Brands, Inc.'s net margin of -47.42%. Tilray Brands, Inc.'s return on equity of -86.4% beat Organigram Global, Inc.'s return on equity of -7.06%.
Company Gross Margin Earnings Per Share Invested Capital TLRY.TOTilray Brands, Inc.25.56% -$0.00 $2.5B OGI.TOOrganigram Global, Inc.0.52% -$0.28 $357.9M -
What do Analysts Say About TLRY.TO or OGI.TO?
Tilray Brands, Inc. has a consensus price target of $16.82, signalling upside risk potential of 21.44%. On the other hand Organigram Global, Inc. has an analysts' consensus of $3.40 which suggests that it could grow by 41.08%. Given that Organigram Global, Inc. has higher upside potential than Tilray Brands, Inc., analysts believe Organigram Global, Inc. is more attractive than Tilray Brands, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLRY.TOTilray Brands, Inc.2 6 0 OGI.TOOrganigram Global, Inc.3 1 0 -
Is TLRY.TO or OGI.TO More Risky?
Tilray Brands, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Organigram Global, Inc. has a beta of 2.213, suggesting its more volatile than the S&P 500 by 121.273%.
-
Which is a Better Dividend Stock TLRY.TO or OGI.TO?
Tilray Brands, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Organigram Global, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tilray Brands, Inc. pays -- of its earnings as a dividend. Organigram Global, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLRY.TO or OGI.TO?
Tilray Brands, Inc. quarterly revenues are $287.4M, which are larger than Organigram Global, Inc. quarterly revenues of $80.1M. Tilray Brands, Inc.'s net income of $2.1M is higher than Organigram Global, Inc.'s net income of -$38M. Notably, Tilray Brands, Inc.'s price-to-earnings ratio is -- while Organigram Global, Inc.'s PE ratio is 129.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tilray Brands, Inc. is 3.46x versus 1.20x for Organigram Global, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLRY.TOTilray Brands, Inc.3.46x -- $287.4M $2.1M OGI.TOOrganigram Global, Inc.1.20x 129.47x $80.1M -$38M
-
Which has Higher Returns TLRY.TO or WEED.TO?
Canopy Growth Corp. has a net margin of 0.72% compared to Tilray Brands, Inc.'s net margin of -2.46%. Tilray Brands, Inc.'s return on equity of -86.4% beat Canopy Growth Corp.'s return on equity of -68.7%.
Company Gross Margin Earnings Per Share Invested Capital TLRY.TOTilray Brands, Inc.25.56% -$0.00 $2.5B WEED.TOCanopy Growth Corp.25.3% -$0.01 $995.3M -
What do Analysts Say About TLRY.TO or WEED.TO?
Tilray Brands, Inc. has a consensus price target of $16.82, signalling upside risk potential of 21.44%. On the other hand Canopy Growth Corp. has an analysts' consensus of $3.76 which suggests that it could grow by 111.24%. Given that Canopy Growth Corp. has higher upside potential than Tilray Brands, Inc., analysts believe Canopy Growth Corp. is more attractive than Tilray Brands, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLRY.TOTilray Brands, Inc.2 6 0 WEED.TOCanopy Growth Corp.1 4 1 -
Is TLRY.TO or WEED.TO More Risky?
Tilray Brands, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Canopy Growth Corp. has a beta of 1.930, suggesting its more volatile than the S&P 500 by 92.97%.
-
Which is a Better Dividend Stock TLRY.TO or WEED.TO?
Tilray Brands, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Canopy Growth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tilray Brands, Inc. pays -- of its earnings as a dividend. Canopy Growth Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLRY.TO or WEED.TO?
Tilray Brands, Inc. quarterly revenues are $287.4M, which are larger than Canopy Growth Corp. quarterly revenues of $66.7M. Tilray Brands, Inc.'s net income of $2.1M is higher than Canopy Growth Corp.'s net income of -$1.6M. Notably, Tilray Brands, Inc.'s price-to-earnings ratio is -- while Canopy Growth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tilray Brands, Inc. is 3.46x versus 1.16x for Canopy Growth Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLRY.TOTilray Brands, Inc.3.46x -- $287.4M $2.1M WEED.TOCanopy Growth Corp.1.16x -- $66.7M -$1.6M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 0.7% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 0.71% over the past day.
Buy
66
ASTS alert for Dec 26
AST Spacemobile, Inc. [ASTS] is down 7.39% over the past day.
